Literature DB >> 12414130

Brucellosis in Mexico: current status and trends.

J Eduardo Luna-Martínez1, Claudia Mejía-Terán.   

Abstract

Traditionally, Mexico has been recognized as endemic with brucellosis. The improvements in diagnostics techniques and vaccination strategies and the enforcement of a national eradication policy have contributed significantly to making progress in the control of brucellosis. The current status of brucellosis and its risk factors, in the different production species as well as in human population is reviewed. Also the trends in control and eventual eradication strategies and perspectives for the near future of Mexico are presented. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12414130     DOI： 10.1016/s0378-1135(02)00241-9

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN： 0378-1135            Impact factor:   3.293


  15 in total

1.  Brucella abortus exposure during an orthopedic surgical procedure in New Mexico, 2010.

Authors:  Megin Nichols; Deborah Thompson; Joshua T Carothers; Judy Klauber; Robyn A Stoddard; Marta A Guerra; Tina J Benoit; Rita M Traxler
Journal:  Infect Control Hosp Epidemiol       Date:  2014-06-20       Impact factor: 3.254

2.  Serial kinetics of the antibody response against the complete Brucella melitensis ORFeome in focal vertebral brucellosis.

Authors:  Anthony P Cannella; Jennifer C Lin; Li Liang; Vidya Atluri; Eduardo Gotuzzo; Philip L Felgner; Renee M Tsolis; Joseph M Vinetz
Journal:  J Clin Microbiol       Date:  2012-01-04       Impact factor: 5.948

3.  Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.

Authors:  Morteza Abkar; Abbas Sahebghadam Lotfi; Jafar Amani; Khadijeh Eskandari; Mehdi Fasihi Ramandi; Jafar Salimian; Gholamreza Nikbakht Brujeni; Saeed Alamian; Mehdi Kamali; Hamid Koushki
Journal:  Vet Res Commun       Date:  2015-09-22       Impact factor: 2.459

4.  Milk yield and reproductive performance of brucellosis-vaccinated but seropositive Holstein cows.

Authors:  Miguel Mellado; Angel M Garcia; Beatriz Arellano-Reynoso; Efren Diaz-Aparicio; Jose E Garcia
Journal:  Trop Anim Health Prod       Date:  2013-11-20       Impact factor: 1.559

Review 5.  The current therapeutical strategies in human brucellosis.

Authors:  Mile Bosilkovski; Fariba Keramat; Jurica Arapović
Journal:  Infection       Date:  2021-03-01       Impact factor: 3.553

6.  Establishment of systemic Brucella melitensis infection through the digestive tract requires urease, the type IV secretion system, and lipopolysaccharide O antigen.

Authors:  Tatiane A Paixão; Christelle M Roux; Andreas B den Hartigh; Sumathi Sankaran-Walters; Satya Dandekar; Renato L Santos; Renée M Tsolis
Journal:  Infect Immun       Date:  2009-08-03       Impact factor: 3.441

7.  Brucella isolated in humans and animals in Latin America from 1968 to 2006.

Authors:  N E Lucero; S M Ayala; G I Escobar; N R Jacob
Journal:  Epidemiol Infect       Date:  2007-06-11       Impact factor: 2.451

8.  Evaluation of serological diagnostic tests of human brucellosis for prevention and control in Mexico.

Authors:  Carmen Guzmán-Bracho; Berenice Salgado-Jiménez; Liz G Beltrán-Parra; Irma Hernández-Monroy; Fernando Vargas-Pino; Demetrio Rodríguez; Irma López-Martínez; Sergio Pastén-Sánchez; Jesús F González-Roldán; Jorge Membrillo-Hernández; José Alberto Díaz-Quiñónez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-01-20       Impact factor: 3.267

9.  Seroprevalence and risk factors for bovine brucellosis in Jordan.

Authors:  Ahmad M Al-Majali; Abdelsalam Q Talafha; Mustafa M Ababneh; Mohammed M Ababneh
Journal:  J Vet Sci       Date:  2009-03       Impact factor: 1.672

Review 10.  A history of the development of Brucella vaccines.

Authors:  Eric Daniel Avila-Calderón; Ahidé Lopez-Merino; Nammalwar Sriranganathan; Stephen M Boyle; Araceli Contreras-Rodríguez
Journal:  Biomed Res Int       Date:  2013-06-03       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.